These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8937795)

  • 1. Neuroleptic malignant syndrome while on tiapride treatment.
    Duarte J; Campos JM; Cabezas C; Sagredo V; Cortina J; Clavería LE
    Clin Neuropharmacol; 1996 Dec; 19(6):539-40. PubMed ID: 8937795
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetrabenazine as a cause of neuroleptic malignant syndrome.
    Ossemann M; Sindic CJ; Laterre C
    Mov Disord; 1996 Jan; 11(1):95. PubMed ID: 8771075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant Neuroleptic Syndrome during tiapride treatment].
    Tamion F; Petit J; Massari P; Leroy J; Biga N; Oksenhendler G
    J Toxicol Clin Exp; 1990; 10(7-8):461-7. PubMed ID: 2135061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed type malignant syndrome and Parkinson's syndrome due to tiapride, Reye-like syndrome induced by calcium hopantenate].
    Noda S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):538-41. PubMed ID: 10434717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome induced by a single injection of tiapride].
    Xerri B; Lefevre MM; Paolaggi JB
    Rev Rhum Ed Fr; 1994 May; 61(5):362. PubMed ID: 7812295
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
    Petzinger GM; Bressman SB
    Mov Disord; 1997 Mar; 12(2):246-8. PubMed ID: 9087987
    [No Abstract]   [Full Text] [Related]  

  • 7. Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation.
    Kadyan V; Colachis SC; Depalma MJ; Sanderson JD; Mysiw WJ
    Brain Inj; 2003 Jul; 17(7):631-7. PubMed ID: 12775273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome and tiapride].
    Faitg R; Coulaud JM; Rezgui N; Sultan S; Lissac J
    J Toxicol Clin Exp; 1989; 9(5):333-5. PubMed ID: 2632786
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus.
    Sule A; Gohar S; Mittal G; Balakrishnan C; Mangat G; Joshi VR
    J Assoc Physicians India; 2000 Apr; 48(4):437-8. PubMed ID: 11273184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome and mental retardation: review and analysis of 29 cases.
    Boyd RD
    Am J Ment Retard; 1993 Jul; 98(1):143-55. PubMed ID: 8103996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The malignant neuroleptic syndrome].
    Pietzcker A
    Nervenarzt; 1988 Dec; 59(12):691-700. PubMed ID: 2905769
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome--in need of acute care].
    Poutanen O; Kiviniemi P
    Duodecim; 2004; 120(2):163-8. PubMed ID: 15065507
    [No Abstract]   [Full Text] [Related]  

  • 14. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
    Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
    J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypophosphatemia and neuroleptic malignant syndrome.
    Seitz DP
    J Clin Psychopharmacol; 2007 Jun; 27(3):302-3. PubMed ID: 17502779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.